Axsome Therapeutics (AXSM) PT Raised to $246 at Baird

May 4, 2026 4:17 PM

Baird analyst Joel Beatty raised the price target on Axsome Therapeutics (NASDAQ: AXSM) to $246.00 (from $241.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found